Literature DB >> 12934667

Impact of proapoptotic proteins Bax and Bak in tumor progression and response to treatment.

Pierre-François Cartron1, Philippe Juin, Lisa Oliver, Khaled Meflah, François M Vallette.   

Abstract

The cell death program, apoptosis, is currently viewed as the ultimate obstacle in cancer therapy. Inhibition of apoptosis is thought to be involved in both tumorigenesis and resistance to chemo- and radiotherapy. Considerable efforts are underway to design new tools capable of overcoming this inhibition. In this review, the current understanding of mechanisms of apoptosis in normal and tumor cells as well as possible or existing strategies designed to induce specific and efficient cell death in cancers are summarized.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12934667     DOI: 10.1586/14737140.3.4.563

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  16 in total

1.  Genomic amplification and a role in drug-resistance for the KDM5A histone demethylase in breast cancer.

Authors:  Jinling Hou; Jack Wu; Alan Dombkowski; Kezhong Zhang; Andreana Holowatyj; Julie L Boerner; Zeng-Quan Yang
Journal:  Am J Transl Res       Date:  2012-07-22       Impact factor: 4.060

2.  Alpha 1-antitrypsin ameliorates ventilator-induced lung injury in rats by inhibiting inflammatory responses and apoptosis.

Authors:  He Zhu; Jianshuai He; Jia Liu; Xin Zhang; Fengyun Yang; Pingting Liu; Shilei Wang
Journal:  Exp Biol Med (Maywood)       Date:  2017-11-02

3.  Decoding the concealed transcriptional signature of the apoptosis-related BCL2 antagonist/killer 1 (BAK1) gene in human malignancies.

Authors:  Konstantina Athanasopoulou; Panagiotis G Adamopoulos; Glykeria N Daneva; Andreas Scorilas
Journal:  Apoptosis       Date:  2022-07-25       Impact factor: 5.561

4.  Endogenous Bak inhibitors Mcl-1 and Bcl-xL: differential impact on TRAIL resistance in Bax-deficient carcinoma.

Authors:  Bernhard Gillissen; Jana Wendt; Antje Richter; Anja Richter; Annika Müer; Tim Overkamp; Nina Gebhardt; Robert Preissner; Claus Belka; Bernd Dörken; Peter T Daniel
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

5.  BAK, BAX, and NBK/BIK proapoptotic gene alterations in Iranian patients with ataxia telangiectasia.

Authors:  Anna Isaian; Natalia V Bogdanova; Masoud Houshmand; Masoud Movahadi; Asghar Aghamohammadi; Asghar Agamohammadi; Nima Rezaei; Lida Atarod; Mahnaz Sadeghi-Shabestari; Seyed Hasan Tonekaboni; Zahra Chavoshzadeh; Seyed Mohammad Seyed Hassani; Reza Mirfakhrai; Taher Cheraghi; Najmoddin Kalantari; Mitra Ataei; Thilo Dork-Bousset; Mohammad Hossein Sanati
Journal:  J Clin Immunol       Date:  2009-11-07       Impact factor: 8.317

6.  Glucose deprivation increases nuclear DNA repair protein Ku and resistance to radiation induced oxidative stress in human cancer cells.

Authors:  Jie Li; Roashan Ayene; Kathleen M Ward; Eswarkumar Dayanandam; Iraimoudi S Ayene
Journal:  Cell Biochem Funct       Date:  2009-03       Impact factor: 3.685

7.  Ac2-26 mitigated acute respiratory distress syndrome rats via formyl peptide receptor pathway.

Authors:  Yingnan Ju; Lin Qiu; Xikun Sun; Hengyu Liu; Wei Gao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

8.  Essential requirement of cytochrome c release for caspase activation by procaspase-activating compound defined by cellular models.

Authors:  M Seervi; J Joseph; P K Sobhan; B C Bhavya; T R Santhoshkumar
Journal:  Cell Death Dis       Date:  2011-09-08       Impact factor: 8.469

9.  Opposite role of Bax and BCL-2 in the anti-tumoral responses of the immune system.

Authors:  Gwenola Bougras; Pierre-François Cartron; Fabien Gautier; Stéphane Martin; Marité LeCabellec; Khaled Meflah; Marc Gregoire; François M Vallette
Journal:  BMC Cancer       Date:  2004-08-24       Impact factor: 4.430

10.  Lipoxin A4 attenuates the lung ischaemia reperfusion injury in rats after lung transplantation.

Authors:  Lijuan Zhang; Qihang Tai; Guangxiao Xu; Wei Gao
Journal:  Ann Med       Date:  2021-12       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.